Veletri is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Epoprostenol.
| Product ID | 66215-402_1bec1b5a-5956-4b0a-b46e-c85a051d1631 |
| NDC | 66215-402 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Veletri |
| Generic Name | Epoprostenol |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-04-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022260 |
| Labeler Name | Actelion Pharmaceuticals US, Inc. |
| Substance Name | EPOPROSTENOL |
| Active Ingredient Strength | 2 mg/10mL |
| Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2010-04-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022260 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-04-22 |
| Ingredient | Strength |
|---|---|
| EPOPROSTENOL | 1.5 mg/10mL |
| SPL SET ID: | df502787-46ec-4dd1-a2c0-be90f6d95a5d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66215-402 | Veletri | epoprostenol |
| 66215-403 | Veletri | epoprostenol |
| 62756-059 | epoprostenol | epoprostenol |
| 62756-060 | epoprostenol | epoprostenol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VELETRI 79070519 3818540 Live/Registered |
Actelion Pharmaceuticals Ltd. 2009-06-05 |
![]() VELETRI 77871287 not registered Dead/Abandoned |
Actelion Pharmaceuticals Ltd. 2009-11-12 |
![]() VELETRI 76289963 2720582 Live/Registered |
Actelion Pharmaceuticals Ltd. 2001-07-25 |